Vivos Therapeutics Inc (VVOS) Stock Price, Quote & News

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test...

Industry: Medical Devices

Sector: Healthcare

Phone: 866 908 4867

Website: www.vivos.com

Address:

7921 Southpark Plaza, Suite 210, Littleton, United States

exile0002 Aug. 8 at 5:44 PM

$VVOS omg ... go home shorty .... 😅👎

1 · Reply

Loopi Aug. 8 at 4:54 PM

$VVOS going to $0.11 very soon 🛑❌

0 · Reply

Giovannirs3 Aug. 8 at 12:01 PM

$VVOS 🫡

0 · Reply

stockpicker12e Aug. 8 at 11:05 AM

$VVOS it seems to me that Kirk is setting up for a big stock increase. I have seen this before and i made alot of money.

0 · Reply

exile0002 Aug. 8 at 9:23 AM

$VVOS interesting setup 😏👍

0 · Reply

Boywithathorn Aug. 7 at 9:05 PM

$VVOS 7k shares 32 cents. I’d love to double and make 2k. But I’ll prob lose a few hundred instead looking at crazy yearly chart.

0 · Reply

Schizoo Aug. 7 at 8:13 PM

$AEMD $PCSA $GVH $VVOS $PLRZ My swings for next week.. BALLS N PATIENCE PEOPLE 😘 ALL LOW FLOATS AND HIGH SHORT..

2 · Reply

betredracing Aug. 7 at 6:18 PM

$VVOS Somebody bought alot of shares this morning. Big news on Monday?

0 · Reply

BudFoxBHS Aug. 7 at 5:19 PM

$VVOS If 2Q results are anything less than at or above projection, it's time to move on from Huntsman. If the Board can't do that, then keep him on as Chairman, but replace him as CEO and build an aggressive C Suite team that can deliver results. The current team has had their opportunity and they have fumbled it quarter after quarter. At some point, you need to change out your players.

1 · Reply

john_diddly Aug. 7 at 5:07 PM

$VVOS -70% since 4/16.

1 · Reply

Vivos Therapeutics issued new U.S. patent for Vivos CARE devices

Aug 5, 2026, 8:30 AM EDT - 3 days ago

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

2026-07-08T18:10:16.000Z - 4 weeks ago

Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global

2026-06-30T13:35:46.000Z - 5 weeks ago

Vivos Therapeutics says Vida oral appliance improves insomnia in study

Jun 30, 2026, 8:45 AM EDT - 5 weeks ago

Vivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants

Jun 22, 2026, 8:30 AM EDT - 6 weeks ago

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

2026-06-11T12:55:08.000Z - 2 months ago

Vivos Therapeutics intends to file registration statement for rights offering

Jun 11, 2026, 8:30 AM EDT - 2 months ago

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

2026-06-10T13:18:43.000Z - 2 months ago

Vivos Therapeutics enters pact with South Palm Cardiovascular Associates

Jun 10, 2026, 9:03 AM EDT - 2 months ago

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

Jun 9, 2026, 11:30 AM EDT - 2 months ago

Vivos Therapeutics Transcript: WTR Insights Conference: Powered by The Small Cap Showcase

Jun 8, 2026, 1:39 PM EDT - 2 months ago

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

Jun 5, 2026, 8:45 AM EDT - 2 months ago

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

2026-05-20T20:22:09.000Z - 2 months ago

Vivos Therapeutics reports Q1 EPS (52c), consensus (45c)

May 20, 2026, 4:10 PM EDT - 2 months ago

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

May 20, 2026, 4:00 PM EDT - 2 months ago

Vivos Therapeutics Quarterly report: Q1 2026

May 20, 2026, 4:00 PM EDT - 2 months ago

Vivos Therapeutics Earnings release: Q1 2026

May 9, 2026, 11:53 AM EDT - 3 months ago

Analysts see 200%+ upside in these 3 high-risk stocks: here's why?

ACTU ATAI

Apr 30, 2026, 8:00 AM EDT - 3 months ago

Vivos Therapeutics Registration statement: Registration filing

2026-04-17T13:52:17.000Z - 4 months ago

Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright

2026-04-17T12:43:47.000Z - 4 months ago

Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global

Apr 15, 2026, 5:00 PM EDT - 4 months ago

Vivos Therapeutics Earnings Call Transcript: Q4 2025

Apr 15, 2026, 5:00 PM EDT - 4 months ago

Vivos Therapeutics Earnings release: Q4 2025

Apr 15, 2026, 5:00 PM EDT - 4 months ago

Vivos Therapeutics Annual report: Q4 2025

Apr 15, 2026, 4:20 PM EDT - 4 months ago

Vivos Therapeutics Reports Full Year 2025 Financial Results

Apr 15, 2026, 8:45 AM EDT - 4 months ago

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

Apr 7, 2026, 8:45 AM EDT - 4 months ago

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

Mar 26, 2026, 8:45 AM EDT - 4 months ago

Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

2026-03-17T13:00:18.000Z - 5 months ago

Vivos Therapeutics’ oral medical devices proven to enhance airways

Mar 17, 2026, 8:45 AM EDT - 5 months ago

Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

Feb 17, 2026, 7:00 AM EST - 6 months ago

Vivos Therapeutics Registration statement: Registration Filing

2026-02-17T11:15:45.000Z - 6 months ago

Vivos Therapeutics files to sell 3.96M shares of common stock for holders

2026-02-05T13:50:40.000Z - 6 months ago

Vivos, SoundHealth collaborate to expand access to SoundHealth’s technology

2026-02-05T13:50:12.000Z - 6 months ago

Vivos Therapeutics signs 12-part media series with New to the Street

Feb 5, 2026, 8:45 AM EST - 6 months ago

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Jan 20, 2026, 5:31 PM EST - 7 months ago

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

2026-01-16T13:10:49.000Z - 7 months ago

Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds

Jan 16, 2026, 8:00 AM EST - 7 months ago

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Dec 16, 2025, 11:00 AM EST - 8 months ago

Vivos Therapeutics Transcript: Fireside Chat

2025-12-16T13:50:29.000Z - 8 months ago

Vivos Therapeutics opens sleep center in Auburn Hills, Michigan

Dec 16, 2025, 8:45 AM EST - 8 months ago

Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

Nov 19, 2025, 5:00 PM EST - 9 months ago

Vivos Therapeutics Earnings Call Transcript: Q3 2025

Nov 19, 2025, 5:00 PM EST - 9 months ago

Vivos Therapeutics Earnings release: Q3 2025

Nov 19, 2025, 5:00 PM EST - 9 months ago

Vivos Therapeutics Quarterly report: Q3 2025

2025-11-19T21:30:18.000Z - 9 months ago

Vivos Therapeutics reports Q3 EPS (49c), consensus (51c)

Nov 19, 2025, 4:20 PM EST - 9 months ago

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Nov 19, 2025, 8:30 AM EST - 9 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

2025-11-17T11:15:44.000Z - 9 months ago

Vivos Therapeutics initiated with a Buy at H.C. Wainwright

2025-09-30T12:45:33.000Z - 11 months ago

Vivos Therapeutics announces additional data from use of Vivos DNA device

Sep 30, 2025, 8:30 AM EDT - 11 months ago

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Sep 29, 2025, 8:00 AM EDT - 11 months ago

Vivos Therapeutics Proxy statement: Proxy Filing

2025-09-17T12:41:24.000Z - 11 months ago

Vivos Therapeutics announces trial results in pediatric OSA treatment

Sep 17, 2025, 8:30 AM EDT - 11 months ago

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

Sep 5, 2025, 8:00 AM EDT - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Aug 19, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q2 2025

Aug 19, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings release: Q2 2025

Aug 19, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Quarterly report: Q2 2025

Aug 19, 2025, 4:20 PM EDT - 1 year ago

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Aug 19, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

2025-07-30T12:50:50.000Z - 1 year ago

Vivos Therapeutics appoints Bruhn as EVP, Jones as SVP

2025-07-01T12:40:14.000Z - 1 year ago

Vivos Therapeutics receives Medicare approval for VidaSleep Oral Applicance

Jun 26, 2025, 8:30 AM EDT - 1 year ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q1 2025

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings release: Q1 2025

May 15, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Quarterly report: Q1 2025

May 14, 2025, 9:15 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q4 2024

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Earnings release: Q4 2024

Mar 31, 2025, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Annual report: Q4 2024

Mar 31, 2025, 4:20 PM EDT - 1 year ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Feb 18, 2025, 12:00 PM EST - 1 year ago

Vivos Therapeutics Transcript: Fireside Chat

Feb 11, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Jan 29, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Jan 22, 2025, 7:00 AM EST - 1 year ago

Vivos Therapeutics Registration statement: Registration Filing

Dec 23, 2024, 8:00 AM EST - 1 year ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Quarterly report: Q3 2024

Nov 13, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Nov 6, 2024, 7:00 AM EST - 1 year ago

Vivos Therapeutics Proxy statement: Proxy Filing

Oct 8, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Oct 7, 2024, 8:00 AM EDT - 1 year ago

Vivos Therapeutics Proxy statement: Proxy Filing

Sep 18, 2024, 7:00 AM EDT - 2 years ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q2 2024

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Quarterly report: Q2 2024

Aug 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q2 2024

Aug 14, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 14, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Jun 27, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 12, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Quarterly report: Q1 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q1 2024

May 14, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 14, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Apr 22, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Apr 9, 2024, 8:00 AM EDT - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q4 2023

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Earnings release: Q4 2023

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Annual report: Q4 2023

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 28, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Feb 6, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Jan 8, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Dec 11, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Nov 30, 2023, 7:00 AM EST - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Nov 29, 2023, 11:09 AM EST - 2 years ago

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

Nov 29, 2023, 7:44 AM EST - 2 years ago

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Nov 29, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Nov 22, 2023, 7:00 AM EST - 2 years ago

Vivos Therapeutics Registration statement: Registration Filing

Nov 14, 2023, 5:00 PM EST - 2 years ago

Vivos Therapeutics Earnings Call Transcript: Q3 2023

Nov 14, 2023, 5:00 PM EST - 2 years ago

Vivos Therapeutics Quarterly report: Q3 2023

Nov 14, 2023, 5:00 PM EST - 2 years ago

Vivos Therapeutics Earnings release: Q3 2023

Nov 14, 2023, 4:05 PM EST - 2 years ago

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Nov 9, 2023, 4:30 PM EST - 2 years ago

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

exile0002 Aug. 8 at 5:44 PM

$VVOS omg ... go home shorty .... 😅👎

1 · Reply

Loopi Aug. 8 at 4:54 PM

$VVOS going to $0.11 very soon 🛑❌

0 · Reply

Giovannirs3 Aug. 8 at 12:01 PM

$VVOS 🫡

0 · Reply

stockpicker12e Aug. 8 at 11:05 AM

$VVOS it seems to me that Kirk is setting up for a big stock increase. I have seen this before and i made alot of money.

0 · Reply

exile0002 Aug. 8 at 9:23 AM

$VVOS interesting setup 😏👍

0 · Reply

Boywithathorn Aug. 7 at 9:05 PM

$VVOS 7k shares 32 cents. I’d love to double and make 2k. But I’ll prob lose a few hundred instead looking at crazy yearly chart.

0 · Reply

Schizoo Aug. 7 at 8:13 PM

$AEMD $PCSA $GVH $VVOS $PLRZ My swings for next week.. BALLS N PATIENCE PEOPLE 😘 ALL LOW FLOATS AND HIGH SHORT..

2 · Reply

betredracing Aug. 7 at 6:18 PM

$VVOS Somebody bought alot of shares this morning. Big news on Monday?

0 · Reply

BudFoxBHS Aug. 7 at 5:19 PM

1 · Reply

john_diddly Aug. 7 at 5:07 PM

$VVOS -70% since 4/16.

1 · Reply

john_diddly Aug. 7 at 5:03 PM

$VVOS Huntsman is so quick to use the ATM even at these depressed prices because that money goes straight to his pockets. He stopped caring about the success of the company a long time ago. He only cares about how many more times he can get his biweekly ~$20K direct deposit.

0 · Reply

PirataCodex Aug. 7 at 4:49 PM

$VVOS clearly a large hidden seller at 32 cents

0 · Reply

ka1954 Aug. 7 at 4:34 PM

$VVOS this fucker cant even be positive at lowest price. piece of crap

0 · Reply

Schizoo Aug. 7 at 4:32 PM

$VVOS its friday.. buy n hold for next week. Should see some action.

0 · Reply

Rounderssss4 Aug. 7 at 4:31 PM

$VVOS are you kidding me back to .32🤦

0 · Reply

PirataCodex Aug. 7 at 4:02 PM

$VVOS this stock is HIGHLY allergic to being over 36 cents..

0 · Reply

SilentSniper Aug. 7 at 3:52 PM

$VVOS this one is oversold..all u need is a bit of patience with it..low float..wild swings either direction..can go up as quickly as it came down

0 · Reply

PirataCodex Aug. 7 at 3:51 PM

$VVOS hahah now someone buys 28 k shares and it barely moves the needle

0 · Reply

Schizoo Aug. 7 at 3:50 PM

$AEMD low float high short.. $VVOS high short.. $GVH low float high short.. The result when they cover is like $YJ 🤷‍♂️🤌🚀🚀🚀🚀

1 · Reply

PirataCodex Aug. 7 at 3:46 PM

$VVOS its crazy how 25k shares can dump this stock all the way back down haha wtf

0 · Reply

Moneyybaggs Aug. 7 at 3:28 PM

$VVOS Shorts might want to consider covering, they’ve had an amazing ride. Now it’s time for us longs to rip their FOOKIN faces off!!! FMTT!!!

0 · Reply

SilentSniper Aug. 7 at 3:17 PM

$VVOS

0 · Reply

Market Cap	4.47M
Revenue (ttm)	17.44M
Net Income (ttm)	-21.17M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-121.39%
Debt to Equity Ratio	-6.08

Volume	1,329,400
Avg Vol	2,899,648
Day's Range	N/A - N/A
Shares Out	13.90M
Stochastic %K	9%
Beta	6.22
Analysts	Sell
Price Target	$2.12